Cyclo Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Cyclo Therapeutics

17/08/2021 13:31

* Cyclo Therapeutics Inc  CYTH.OQ  reported a quarterly adjusted
loss of 56 cents​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of 76 cents
per share.
* Revenue was $239.00 thousand​;  analysts expected $360.00
thousand. 
* Cyclo Therapeutics Inc's reported EPS for the quarter was a
loss of 56 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Cyclo Therapeutics Inc shares had fallen by 31.2% this
quarter and gained 61.8% so far this year.
* The company reported a quarterly loss of $3.6 million.
* Wall Street's median 12-month price target for Cyclo
Therapeutics Inc is $25.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 17 at 12:31 p.m.  ​All
figures in US dollars unless otherwise stated